China on Wednesday said it would spare a number of US products from punitive tariffs in what is seen as an olive branch by Beijing in the protracted trade war ahead of high-level talks next month. Welcoming China's decision to exempt some US anti-cancer drugs and other goods from its tariffs, US President Donald Trump announced a short delay to scheduled tariff hikes on billions worth of Chinese goods.
China's exemptions, however, do not include big-ticket agricultural items that could be crucial to the ultimate success of any agreement between the two sides, whose stand-off is dragging on the global economy.
The exemptions will become effective on September 17 and be valid for a year, according to the Customs Tariff Commission of the State Council, which released two lists that include seafood products and anti-cancer drugs.
The lists mark the first time Beijing has announced products to be excluded from tariffs. China’s decision was a “big move” by Beijing and a positive gesture before trade negotiators from both countries meet in Washington, Trump told reporters at the White House.
Other categories that will become exempt include alfalfa pellets, fish feed, medical linear accelerators and mould release agents, while the commission said it was also considering further exemptions.
Trade negotiators have said they will meet in Washington in early October, raising hopes for an easing of tensions between the world's two biggest economies.
Both sides imposed fresh tit-for-tat tariffs on September 1 in the latest round of levies, which now cover goods worth hundreds of billions of dollars.
"These adjustments signal that China is more willing to make progress in the October trade talks, likely toward striking a 'narrow' agreement that involves China buying more US goods in exchange for the US suspending further tariff hikes," Barclays analysts said in a research note.
The analysts said Beijing had been sounding a more "constructive" note in recent weeks over trade relations. US businesses in China are increasingly pessimistic about their prospects, with a report released Wednesday saying growing numbers of companies expect their revenues and investment in the local market to shrink.
The American Chamber of Commerce in Shanghai said just 47 per cent said they expected to increase their investments in China in 2019—down from 62 per cent last year—while three-quarters of businesses surveyed said they opposed the use of punitive tariffs by the US to force China into a trade deal.
